Hygiene
Conditions
Brief summary
Primary Objective: To prove the safety of the formulation in normal conditions of use.
Interventions
DRUGLACTIC ACID(ND)
Dermacyd Infantile (LACTIC ACID)
Sponsors
Sanofi
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
No minimum to 12 Years
Healthy volunteers
Yes
Inclusion criteria
* Integral skin test in the region * Use the same category of cosmetics * Willingness in following the study procedures and to be present in the clinic at the days and scheduled time.
Exclusion criteria
* Use of Anti-inflammatory, immunosuppressant or anti-histaminic drugs * Allergic or atopic history to cosmetics products * Cutaneous active disease (local or general) in the evaluated area * Disease which can cause immunosuppressant, such as diabetes, HIV * Endocrine pathology * Intensive solar exposure until 15 days before evaluation * Treatment four months before selection. The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The absence of irritation and the good acceptability will be evaluated using one specific scale which describes the intensity of the reaction. | From the treatment start to the end of the study |
Countries
Brazil
Outcome results
None listed